FDA Announces Public Meeting on Out-of-Specification Laboratory Test Results in Pharmaceutical Production

Summary

The Food and Drug Administration (FDA) is hosting a public meeting to discuss guidance on evaluating and responding to out-of-specification laboratory test results used in pharmaceutical production, a critical aspect of ensuring the quality and safety of medications.